/
/
/

Blue Jet Healthcare Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-14%10%-8%
-12%16%-19%
----14%
30%28%24%20%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
BLUEJET
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
573.75₹11076 Cr47.154.5113.73₹248 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
——————
₹35 Cr₹35 Cr₹35 Cr₹35 Cr₹35 Cr₹10 Cr
₹1325 Cr₹1098 Cr₹811 Cr₹647 Cr₹487 Cr₹330 Cr
₹1325 Cr₹1098 Cr₹811 Cr₹647 Cr₹487 Cr₹330 Cr
₹1360 Cr₹1133 Cr₹845 Cr₹681 Cr₹522 Cr₹340 Cr
₹0₹0₹0₹0₹0₹29 Cr
₹11 Cr₹7 Cr₹3 Cr₹1 Cr₹26 L₹1 Cr
₹38 Cr₹17 Cr₹38 L₹2 Cr₹13 Cr₹1 L
₹302 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr
₹350 Cr₹29 Cr₹8 Cr₹7 Cr₹17 Cr₹33 Cr
——————
₹57 Cr₹89 Cr₹30 Cr₹54 Cr₹57 Cr₹60 Cr
₹56 Cr₹34 Cr₹51 Cr₹39 Cr₹32 Cr₹46 Cr
₹0₹0₹0₹0₹0₹7 Cr
₹164 Cr₹378 Cr₹281 Cr₹226 Cr₹170 Cr₹107 Cr
₹277 Cr₹501 Cr₹362 Cr₹318 Cr₹259 Cr₹220 Cr
₹1987 Cr₹1662 Cr₹1214 Cr₹1007 Cr₹798 Cr₹593 Cr
₹68 L₹68 L₹1 Cr₹12 Cr₹2 Cr₹2 Cr
₹0₹0₹0₹0₹0₹52 Cr
——————
₹458 Cr₹421 Cr₹276 Cr₹231 Cr₹215 Cr₹176 Cr
₹141 Cr₹121 Cr₹104 Cr₹80 Cr₹58 Cr₹37 Cr
₹316 Cr₹300 Cr₹172 Cr₹151 Cr₹156 Cr₹139 Cr
₹301 Cr₹89 Cr₹147 Cr₹30 Cr₹3 Cr₹3 Cr
₹25 Cr₹0₹15 Cr₹0₹0₹0
₹25 Cr₹0₹15 Cr₹0₹0₹0
₹324 Cr₹22 Cr₹19 Cr₹15 Cr₹5 Cr₹5 Cr
₹14 Cr₹39 L₹24 L₹17 L₹10 L₹8 L
₹981 Cr₹412 Cr₹353 Cr₹197 Cr₹165 Cr₹146 Cr
——————
₹227 Cr₹187 Cr₹235 Cr₹189 Cr₹94 Cr₹37 Cr
₹187 Cr₹264 Cr₹130 Cr₹126 Cr₹105 Cr₹118 Cr
₹339 Cr₹350 Cr₹177 Cr₹239 Cr₹227 Cr₹144 Cr
₹149 Cr₹120 Cr₹85 Cr₹66 Cr₹88 Cr₹70 Cr
₹18 Cr₹7 Cr₹15 Cr₹18 Cr₹8 Cr₹4 Cr
₹86 Cr₹324 Cr₹219 Cr₹172 Cr₹111 Cr₹74 Cr
₹1006 Cr₹1251 Cr₹861 Cr₹810 Cr₹633 Cr₹447 Cr
₹730 Cr₹750 Cr₹500 Cr₹491 Cr₹374 Cr₹227 Cr
₹1987 Cr₹1662 Cr₹1214 Cr₹1007 Cr₹798 Cr₹593 Cr
₹78₹65₹49₹39₹30₹3,428
₹78₹65₹49₹39₹30₹20

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
₹333 Cr₹406 Cr₹220 Cr₹217 Cr₹243 Cr₹190 Cr
₹1 Cr-₹8 Cr₹19 Cr₹18 Cr₹7 Cr₹17 Cr
₹109 Cr-₹263 Cr₹13 Cr-₹33 Cr-₹76 Cr-₹73 Cr
₹443 Cr₹135 Cr₹252 Cr₹202 Cr₹174 Cr₹135 Cr
₹334 Cr₹46 Cr₹241 Cr₹142 Cr₹146 Cr₹135 Cr
-₹276 Cr-₹35 Cr-₹264 Cr-₹147 Cr-₹76 Cr-₹56 Cr
-₹31 Cr-₹19 Cr-₹2 Cr-₹4 Cr-₹56 Cr-₹27 Cr
₹28 Cr-₹8 Cr-₹24 Cr-₹10 Cr₹14 Cr₹51 Cr
₹33 Cr₹41 Cr₹65 Cr₹75 Cr₹61 Cr₹10 Cr
₹61 Cr₹33 Cr₹41 Cr₹65 Cr₹75 Cr₹61 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)582.00
Volume (₹)3.92 L
High (₹)592.00
Upper Circuit702.90
Low (₹)571.85
Lower Circuit468.60
Prev Close585.75
52W High (₹)692.90
Price573.75
52W Low (₹)325.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)11075.50 Cr
Div. Yield (%)0.21
PE Ratio47.15
Debt to Equity0.00
Price to Book4.17
Book Value78.40
EPS (TTM)12.41
Face Value2.00
ROE (%)19.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
BLUEJETNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
573.75-1.5 (-0.26%)
571.85
602.65
11,076Cr

Blue Jet Healthcare Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Blue Jet Healthcare Ltd Quaterly Results Key Takeaways